DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 129 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,532,171 | -2.9% | 306,851 | -15.0% | 0.01% | 0.0% |
| Q2 2023 | $4,665,308 | +139204.5% | 361,092 | +5.8% | 0.01% | +25.0% |
| Q1 2023 | $3,349 | -2.5% | 341,420 | +5.8% | 0.00% | -20.0% |
| Q4 2022 | $3,435 | -99.9% | 322,829 | +1.2% | 0.01% | 0.0% |
| Q3 2022 | $3,331,000 | -14.5% | 319,087 | +3.1% | 0.01% | -16.7% |
| Q2 2022 | $3,896,000 | +215.0% | 309,425 | +171.2% | 0.01% | +200.0% |
| Q1 2022 | $1,237,000 | -23.8% | 114,107 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $1,624,000 | -26.7% | 115,455 | +0.1% | 0.00% | -33.3% |
| Q3 2021 | $2,216,000 | +102.6% | 115,352 | +3.8% | 0.00% | +200.0% |
| Q2 2021 | $1,094,000 | -13.2% | 111,108 | -13.4% | 0.00% | -50.0% |
| Q1 2021 | $1,261,000 | +108.4% | 128,231 | -5.6% | 0.00% | +100.0% |
| Q4 2020 | $605,000 | +13.5% | 135,909 | +10.1% | 0.00% | 0.0% |
| Q3 2020 | $533,000 | -54.4% | 123,459 | -6.4% | 0.00% | -50.0% |
| Q2 2020 | $1,170,000 | +225.9% | 131,933 | +29.6% | 0.00% | +100.0% |
| Q1 2020 | $359,000 | -38.3% | 101,799 | -0.0% | 0.00% | 0.0% |
| Q4 2019 | $582,000 | +70.2% | 101,826 | +6.4% | 0.00% | 0.0% |
| Q3 2019 | $342,000 | -0.3% | 95,722 | +11.2% | 0.00% | 0.0% |
| Q2 2019 | $343,000 | -43.5% | 86,052 | +3.6% | 0.00% | 0.0% |
| Q1 2019 | $607,000 | -21.4% | 83,089 | -1.6% | 0.00% | -50.0% |
| Q4 2018 | $772,000 | +9.0% | 84,415 | +47.8% | 0.00% | +100.0% |
| Q3 2018 | $708,000 | -23.5% | 57,130 | -5.9% | 0.00% | -50.0% |
| Q2 2018 | $926,000 | -23.7% | 60,705 | -0.8% | 0.00% | -33.3% |
| Q1 2018 | $1,214,000 | +3.6% | 61,181 | -2.4% | 0.00% | +50.0% |
| Q4 2017 | $1,172,000 | -22.8% | 62,656 | -11.3% | 0.00% | -33.3% |
| Q3 2017 | $1,519,000 | +160.1% | 70,673 | +16.8% | 0.00% | +200.0% |
| Q2 2017 | $584,000 | +119.5% | 60,503 | +35.5% | 0.00% | 0.0% |
| Q1 2017 | $266,000 | +56.5% | 44,638 | +3.8% | 0.00% | – |
| Q4 2016 | $170,000 | -59.5% | 42,990 | +7.3% | 0.00% | -100.0% |
| Q3 2016 | $420,000 | -26.7% | 40,083 | +1.9% | 0.00% | -50.0% |
| Q2 2016 | $573,000 | -18.8% | 39,323 | +7.2% | 0.00% | 0.0% |
| Q1 2016 | $706,000 | -18.9% | 36,683 | +1.8% | 0.00% | -33.3% |
| Q4 2015 | $871,000 | +16.9% | 36,033 | +18.7% | 0.00% | 0.0% |
| Q3 2015 | $745,000 | +28.7% | 30,363 | +22.9% | 0.00% | +50.0% |
| Q2 2015 | $579,000 | -23.9% | 24,697 | -27.2% | 0.00% | 0.0% |
| Q1 2015 | $761,000 | +34.2% | 33,922 | +0.9% | 0.00% | 0.0% |
| Q4 2014 | $567,000 | +28.6% | 33,622 | -89.1% | 0.00% | +100.0% |
| Q3 2014 | $441,000 | – | 308,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |